Status:
UNKNOWN
Chronic Anergic-anhedonic Depression Open Trial
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Depressive Disorder, Treatment-Resistant
Eligibility:
All Genders
18+ years
Brief Summary
A form of depression called 'dopamine-sensitive anergic-anhedonic syndrome is usually resistant to standard therapies (TRAD). On the other hand, they respond to dopaminergic approaches for which recom...
Eligibility Criteria
Inclusion
- Major patient (≥18 years old)
- Man or woman
- Patient covered for consultation at the Expert Resistant Depression Center of Alsace (CEDRA) (CHU-Strasbourg branch) for TRAD between 01 January 2013 and 31 March 2023
- Patient not opposing to the reuse of their data for the purposes of this research
Exclusion
- Patient having expressed opposition to participating in the study
- Patient under judicial protection
- Patient under guardianship or curatorship
Key Trial Info
Start Date :
April 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 22 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06110507
Start Date
April 1 2023
End Date
March 22 2024
Last Update
October 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CENTRE DE NEUROMODULATION NON INVASIVE DE STRASBOURG (CEMNIS) - CHU de Strasbourg - France
Strasbourg, France, 67091